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177Lu refers to rare earth elements from a group of lanthanides. Relative to its short 
time span, 177Lu has virtually pervaded all areas of in vivo radionuclide therapy and 
becomes one of important keys for therapeutic radionuclides of choice for targeted ra-
dionuclide therapy. The rising interest in the use of 177Lu in targeted molecular thera-
pies has primarily developed from recent unmatched advances in molecular and cell 
biology, which include the use of peptides targeted to cell surface receptors, which are 
overexpressed on the surface of tumour cells. Therefore, the use of 177Lu-labelled radi-
opharmaceuticals have been the major factors evoking excitement among researchers 
and capturing the imagination of the clinical community thanks to advances in molec-
ular and cellular biology. In this work, radiopharmaceutical comparison for 177Lu ab-
sorbed dose in health human organs 
and tissues is presented. The compar-
ison between unlabelled 177Lu (ionic 
form) and labelled with 177Lu-MDP 
(methylenediphosphonate) and 177Lu-
MAb (monoclonal antibodies). The 
biokinetic model in each case are de-
scribed and presented. The absorbed 
dose in health human organs and tis-
sues are simulated with two recom-
mended programs WinAct and IDAC 
2.1 (Internal Dose Assessment by 
Computer) software1. The distribution 
of absorbed dose in the main organs 
nearly the same with different in the 
value for the ionic form and 177Lu-
MDP. The absorption in the case of 
ionic form is high (Fig.1). the distri-
bution is completely change while 177Lu-Mab is used. The most absorbed dose fraction 
goes to spleen and liver unlike bone surface absorb nearly 50 % of dose.  
 
1. Mostafa. Y.A.M et al., Radiological Physics and Technology, in press (2019).  
 
 
Fig. 1. Main organs absorbed dose 
 
